
Most cancer patients have a good immune response to COVID-19 mRNA vaccines, new research shows. Two of the three approved vaccines in the United States — Pfizer and Moderna — are mRNA vaccines. Researchers assessed 131 cancer patients and found that 94% developed antibodies to the new coronavirus three to four weeks after their second… read on > read on >